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CDThe purpose of this trial was to examine the effect of independent and deliberate simulator
practice, during nonclinical time, on the performance of an end-to-side microvascular anastomosis
in an in vivo model. Subjects who practiced independently scored significantly higher on the
OSATS scale and the end-product evaluation and performed the anastomosis significantly faster.
We conclude that independent after-hours training should be incorporated into cardiovascular
surgical curricula.Congenital Heart
Disease (CHD)
504 Extracorporeal membrane oxygenation support after the Fontan operation
Kelly L. Rood, MD, Sarah A. Teele, MD, Cindy S. Barrett, MD, Joshua W. Salvin, MD, MPH,
Peter T. Rycus, MPH, Francis Fynn-Thompson, MD, Peter C. Laussen, MBBS, and
Ravi R. Thiagarajan, MBBS, MPH, Boston, Mass, and Ann Arbor, MichPMA review of the Extracorporeal Life Support Organization database of ECMO support after the
Fontan operation in patients demonstrated a hospital survival of 35%. Complications that
occurred during ECMO and the duration of ECMO were associated with mortality in this
patient group.511 Interstage attrition between bidirectional Glenn and Fontan palliation in
children with hypoplastic left heart syndromeSWaldemar F. Carlo, MD, Kathleen E. Carberry, MPH, RN, Jeffrey S. Heinle, MD,
David L. Morales, MD, E. Dean McKenzie, MD, Charles D. Fraser, Jr, MD, and
David P. Nelson, MD, Birmingham, Ala, Houston, Tex, and Cincinnati, OhioET
/BIn this retrospective single-center analysis, we studied a large group of infants with hypoplastic left
heart syndrome and found that significant tricuspid valve regurgitation and low-weight z score at
the time of bidirectional Glenn were important risk factors for interstage attrition between the
Glenn and Fontan palliations.
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d Cardiovascular Surgery c September 2011Puja Banka, MD, Emile Bacha, MD, Andrew J. Powell, MD, Oscar J. Benavidez, MD, and
Tal Geva, MD, Boston, MassInferior sinus venosus defects (ISVDs) are unusual interatrial communications with few published
outcome data. Patients with ISVD have more residual defects and longer durations of
cardiopulmonary bypass and hospitalization compared with patients with secundum atrial septal
defects. Misdiagnosis of ISVD is frequent and associated with worse outcomes than correct
preoperative diagnosis.523 Perioperative cerebral and somatic oxygenation in neonates with hypoplastic
left heart syndrome or transposition of the great arteries
Anselm Uebing, MD, PhD, Anke K. Furck, MD, Jan H. Hansen, MD, Elisabeth Nufer, MS,
Jens Scheewe, MD, Peter D€utschke, MD, Olaf Jung, MD, and Hans-Heiner Kramer, MD, PhD,
Kiel, GermanyDepression of cerebral tissue oxygenation is prevalent among neonates after surgery with
cardiopulmonary bypass for congenital heart disease, regardless of whether univentricular or
biventricular circulation is present. Because routine measures of oxygen delivery fail to indicate
cerebral desaturation, near-infrared spectroscopy seems a valuable adjunct to postoperative
monitoring after such surgery.531 Reporting adverse events in a surgical trial for complex congenital heart
disease: The Pediatric Heart Network experience
Lisa Virzi, RN, MS, MBA, Victoria Pemberton, RNC, MS, CCRC, Richard G. Ohye, MD,
Sarah Tabbutt, MD, PhD, Minmin Lu, MS, Teresa C. Atz, RN, MSN, Teresa Barnard, RN, BSN,
Carolyn Dunbar-Masterson, BA, BSN, RN, Nancy S. Ghanayem, MD, Jeffrey P. Jacobs, MD,
Linda M. Lambert, MSN-cFNP, Alan Lewis, MD, Nancy Pike, RN, PhD, FNP,
Christian Pizarro, MD, Elizabeth Radojewski, RN, CCRP, David Teitel, MD,
Mingfen Xu, RN, MSN, and Gail D. Pearson, MD, ScD, Watertown and Boston, Mass;
Bethesda, Md; Ann Arbor, Mich; Philadelphia, Pa; Charleston, SC; Cincinnati, Ohio; Milwaukee,
Wis; Tampa, Fla; Salt Lake City, Utah; Los Angeles and San Francisco, Calif; Toronto, Ontario,
Canada; and Durham, NCAdverse event reporting based on 6 sentinel events was compared with a standard approach in
a randomized surgical trial in neonates. The sentinel event approach successfully identified the
highest-risk group and resulted in considerably less administrative burden.General Thoracic
Surgery (GTS)
538 Lobectomy leads to optimal survival in early-stage small cell lung cancer:
A retrospective analysis
John M. Varlotto, MD, Abram Recht, MD, John C. Flickinger, MD, Laura N. Medford-Davis, BA,
Anne-Marie Dyer, MS, and Malcolm M. DeCamp, MD, Hershey and Pittsburgh, Pa; Boston,
Mass; and Chicago, IllSmall cell lung cancer is uncommonly diagnosed in stages I or II. Lobectomy without
adjuvant radiotherapy seems to be the optimal local therapy for patients with early-stage
small cell lung cancer. The addition of radiotherapy after sublobar resection does not improve
survival. Radiotherapy should be considered for patients who are unfit for any surgical
resection.)
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d Cardiovascular Surgery c September 2011Thomas Fabian, MD, FCCP, Ayesha S. Bryant, MSPH, MD, Angela L. Mouhlas, MD,
John A. Federico, MD, and Robert J. Cerfolio, MD, FACS, FCCP, Albany, NY,
Birmingham, Ala, and New Haven, ConnFive-year survival of surgically resected, synchronous, N2 negative, non–small cell lung cancer is
excellent, even in patients with bilateral lung lesions that harbor the same histologic features.
Although, the new TNM classification labels this stage of disease as stage IVM1a, survival behaves
more like separate T1 lesions, thus favoring surgical resection.554 The impact of adjuvant brachytherapy with sublobar resection on
pulmonary function and dyspnea in high-risk patients with operable disease:
Preliminary results from the American College of Surgeons Oncology Group
Z4032 Trial
Hiran C. Fernando, MD, Rodney J. Landreneau, MD, Sumithra J. Mandrekar, PhD,
Shauna L. Hillman, MS, Francis C. Nichols, MD, Bryan Meyers, MD, Thomas A. DiPetrillo, MD,
Dwight Heron, MD, David R. Jones, MD, Benedict D. T. Daly, MD, Sandra L. Starnes, MD,
Jeffrey E. Hatter, MD, and Joe B. Putnam, MD, Boston, Mass; Pittsburgh, Pa; Rochester, Minn;
St Louis, Mo; Providence, RI; Charlottesville, Va; Cincinnati, Ohio; Kingston, NY; and Nashville,
TennAmerican College of Surgeons Oncology Group Z4032 study compared sublobar resection with
and without brachytherapy for high-risk patients with stage I lung cancer. Brachytherapy was not
associated with pulmonary function deterioration at 3-month follow-up. The only factor
associated with 3-month predicted forced expiratory volume deterioration was lower-lobe
sublobar resection.563 Emergency operation for penetrating thoracic trauma in a metropolitan
surgical service in South Africa
Damian Luiz Clarke, MMedSci, Muhammed A. Quazi, FRCS, Kriban Reddy, MBBCHB, and
Sandie Rutherford Thomson, ChM, Durban, South AfricaThis audit examines our total experience with penetrating thoracic trauma. It reviews all the
patients who were brought alive to our surgical service and all who were taken directly to the
mortuary. The review indicates that gunshot wounds of the thorax remain more lethal than stab
wounds.Acquired Cardiovascular
Disease (ACD)
569 Mitral valve repair in heart failure: Five-year follow-up from the mitral valve
replacement stratum of the Acorn randomized trial
Michael A. Acker, MD, Mariell Jessup, MD, Steven F. Bolling, MD, Jae Oh, MD,
Randall C. Starling, MD, Douglas L. Mann, MD, Hani N. Sabbah, PhD,
Richard Shemin, MD, James Kirklin, MD, and Spencer H. Kubo, MD, Philadelphia, Pa;
Ann Arbor and Detroit, Mich; Rochester and St Paul, Minn; Cleveland, Ohio; Houston, Tex;
Los Angeles, Calif; and Birmingham, AlaHeart failure patients with mitral valve that underwent mitral valve surgery 6 CorCap were
followed up for 5 years as part of the Acorn FDA trail. Mitral valve repair with or without Acorn
CorCap resulted in significant and stable reverse remodeling for up to 5 years.)
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d Cardiovascular Surgery c September 2011J. Scott Rankin, MD, Olusola Oguntolu, MD, Robert S. Binford, MD, D. Scott Trochtenberg, MD,
Lawrence H. Muhlbaier, PhD, and Charles W. Stratton, MD, Nashville, Tenn, and Durham, NCPulmonary dysfunction/multiorgan failure syndrome, usually caused by pulmonary infection, is
a leading cause of mortality and morbidity after cardiac surgery. In 44 postoperative patients with
refractory pulmonary dysfunction/multiorgan failure syndrome, intravenous immunoglobulin was
administered adjunctively. Clinical status improved significantly (P , .0001), 42 of 44 patients
recovered, and no complications occurred. Increased clinical application seems indicated.581 The easier, the better: Age, creatinine, ejection fraction score for operative
mortality risk stratification in a series of 29,659 patients undergoing elective
cardiac surgery
Marco Ranucci, MD, Serenella Castelvecchio, MD, Massimiliano Conte, MD,
Gianluigi Megliola, MD, Giuseppe Speziale, MD, Flavio Fiore, MD, Fabio Guarracino, MD,
Sabino Scolletta, MD, RicardoMartinez Escobar, MD, Mauro Falco, MD, Elena Bignami, MD, and
Giovanni Landoni, MD, Milan, Lecce, Bari, Pisa, Siena, Brescia, and Rome, ItalyWevalidate the ACEF score to predict operativemortality in elective cardiac operations with a large
multicentric study (29,659 patients from 14 institutions). The ACEF score provided an accuracy
level comparable to that of the euroSCORE, with far superior clinical performance.587 Thoracic endovascular aortic repair: Evolution of therapy, patterns of use, and
results in a 10-year experience
Nimesh D. Desai, MD, PhD, Alberto Pochettino, MD, Wilson Y. Szeto, MD,
G. William Moser, MSN, Patrick J. Moeller, BSc, Nishtha Sodhi, MD, Benjamin Jackson, MD,
Edward Woo, MD, Ronald M. Fairman, MD, and Joseph Bavaria, MD, Philadelphia, PaThoracic aortic stent grafting has been applied to a wide variety of indications. We present our
experience with this emerging technology in 502 consecutive patients over 10 years.595 Influence of patient gender on mortality after aortic valve replacement for
aortic stenosis
Jennifer Higgins, MD, W. R. Eric Jamieson, MD, Osama Benhameid, MD, Jian Ye, MD,
Anson Cheung, MD, Peter Skarsgard, MD, Eva Germann, MSc, Florence Chan, and
Samuel V. Lichtenstein, MD, PhD, Vancouver, British Columbia, CanadaWe performed a retrospective analysis of 3343 patients with aortic stenosis receiving aortic valve
replacement. Male gender increased the risk of late mortality, and a valve size of # 21 mm
increased the risk of early and overall mortality among the male patients only. These differences
need to be taken into consideration preoperatively and require consideration during operative
management.602 Should the proximal arch be routinely replaced in patients with bicuspid aortic
valve disease and ascending aortic aneurysm?
Chan B. Park, MD, Kevin L. Greason, MD, Rakesh M. Suri, MD, Hector I. Michelena, MD,
Hartzell V. Schaff, MD, and Thoralf M. Sundt III, MD, Rochester, Minn, and Seoul, KoreaAlthough an aggressive approach to the ascending aorta is popularly advocated in the setting of
bicuspid aortic valve, the fate of the aortic arch after replacement of the ascending aorta is
unknown. Reoperation for progressive aortic arch dilatation is uncommon. A selective approach to
concomitant arch surgery is appropriate.)
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The Journal of Thoracic and Cardiovascular Surgery c Volume 142, Number 3 19AOguz Yilmaz, MD, Rakesh M. Suri, MD, DPhil, Joseph A. Dearani, MD, Thoralf M. Sundt III, MD,
Richard C. Daly, MD, Harold M. Burkhart, MD, Zhuo Li, MS, Maurice Enriquez-Sarano, MD, and
Hartzell V. Schaff, MD, Rochester, MinnCH
DWe examined the outcomes of mitral valve prolapse patients with less-than-severe functional
tricuspid regurgitation who underwent only mitral valve repair. After mitral repair, overall grade
of tricuspid valve regurgitation decreased significantly within the first year. Female sex,
preoperative atrial fibrillation, and diabetes mellitus predicted increased tricuspid valve
regurgitation with time.614 Role of conservative management in traumatic aortic injury: Comparison
of long-term results of conservative, surgical, and endovascular
treatmentSVictor X. Mosquera, MD, Milagros Marini, MD, PhD, Jose M. Lopez-Perez, MD, PhD, Javier
Mu~niz-Garcia, MD, PhD, Jose M. Herrera, MD, PhD, Ignacio Cao, MD, and Jose J. Cuenca, MD,
A Coru~na, SpainG
TAcute traumatic aortic injuries are uncommon but life-threatening injuries that may occur in
multisystem trauma patients. The natural history of these patients has revealed a marked trend to
develop late aortic-related complications, which may justify an endovascular repair even in some
low-risk patients.622 Bicuspid aortic valve surgery with proactive ascending aorta repairCDLars G. Svensson, MD, PhD, Kyung-Hwan Kim, MD, Eugene H. Blackstone, MD,
Jeevanantham Rajeswaran, MSc, A. Marc Gillinov, MD, Tomislav Mihaljevic, MD,
Brian P. Griffin, MD, Richard Grimm, DO, William J. Stewart, MD, Donald F. Hammer, MD, and
Bruce W. Lytle, MD, Cleveland, OhioAAortic size larger than 4.5 cm or cross-sectional area/height ratio greater than 8 to 10 cm2/m
should be considered triggers for proactive repair of a dilated aorta concomitant with bicuspid
aortic valve surgery because risk is not increased, and late survival improves. More
aggressive resection to reduce risk of subsequent aortic dissection or reoperation is
unwarranted.630 Repair of ascending and transverse aortic archMHazim J. Safi, MD, Charles C. Miller III, PhD, Taek-Yeon Lee, MD, PhD, and
Anthony L. Estrera, MD, Houston and El Paso, Tex; and Seoul, KoreaP
Outcomes of ascending and arch repair have improved with adjuncts for cerebral perfusion.634 Dilatation of the pulmonary autograft and native aorta after the Ross
procedure: A comprehensive echocardiographic study
Obaid Aljassim, MD, Gunnar Svensson, MD, PhD, Sossio Perrotta, MD,
Anders Jeppsson, MD, PhD, and Odd Bech-Hanssen, MD, PhD,
Gothenburg, SwedenB
SET
/A comprehensive echocardiographic study with up to 14 years’ follow-up demonstrates for the first
time a progressive dilatation of both the pulmonary autograft and the native aorta after the Ross
procedure in adults. Native bicuspid valve or the need to downsize the aortic root was not related to
later dilatation.)










S620A The Journal of Thoracic an41 Left ventricular remodeling and mitral valve surgery: Prospective study with
real-time 3-dimensional echocardiography and speckle tracking(continued on page 22A
d Cardiovascular Surgery c September 2011Dimosthenis Pandis, MD, MSc, Julia Grapsa, MD, Thanos Athanasiou, MD, PhD, FECTS,
Prakash Punjabi, MBBS, MChir, FRCS, and Petros Nihoyannopoulos, MD, FRCP, FESC,
London, United KingdomLeft ventricular remodeling was assessed in 40 patients with degenerative mitral valve
regurgitation using real-time 3-dimensional echocardiography and speckle tracking. The left
ventricular volumes were reduced after surgery. Regression analysis demonstrated incremental
favor toward mitral valve repair in reverse ventricular remodeling. It was also proved that late
diastolic velocity, as well as lateral strain, is important for the recurrence of mitral
regurgitation.Online Only: Acquired
Cardiovascular Disease
e71 Cardiovascular surgery risk prediction from the patient’s perspective
Hiroaki Miyata, PhD, Noboru Motomura, MD, PhD, Ryohei Yozu, MD, PhD,
Shunei Kyo, MD, PhD, and Shinichi Takamoto, MD, PhD, for the Japan Cardiovascular Surgery
Database, Tokyo, JapanWe developed outcome prediction models that integrated both clinical processes and structures.
Models indicated good discrimination and calibration, and thus may be valuable for hospital
selection based on individual patient risks and circumstances. We also found that improved surgeon
work environments are important for both surgeons and patients.e77 Noninvasive assessment of filling pressure and left atrial pressure overload in
severe aortic valve stenosis: Relation to ventricular remodeling and clinical
outcome after aortic valve replacement
Jordi S. Dahl, MD, Lars Videbæk, MD, PhD, Mikael K. Poulsen, MD,
Patricia A. Pellikka, MD, FACC, Karsten Veien, MD, Lars Ib Andersen, MD, DMSci,
Torben Haghfelt, MD, DMSci, FACC, and Jacob E. Møller, MD, PhD, DMSci,
Odense and Copenhagen, Denmark; and Rochester, MinnIn patients with symptomatic severe aortic valve stenosis undergoing aortic valve replacement, left
atrial volume index is a predictor for postoperative survival and morbidity when correcting for
standard risk factors. Severe preoperative left atrial dilatation is associated with increased left
ventricular filling pressures 12 months after surgery.e85 Surgery for patients withMarfan syndromewith type A dissection involving the
aortic arch using total arch replacement combined with stented elephant trunk
implantation: The acute versus the chronic
LiZhong Sun, MD, Ming Li, MD, JunMing Zhu, MD, YongMin Liu, MD,
Qian Chang, MD, Jun Zheng, MD, and RuiDong Qi, MD, Beijing,
Urumqi, and Tianjin, ChinaTotal arch replacement combined with stented elephant trunk can be performed in patients with
Marfan syndrome with type A dissection, especially in patients with chronic dissection. This
technique may induce thrombosis of the false lumen in the distal aorta and facilitate staged aortic
replacement if the false lumen remains patent and dilated.)
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d Cardiovascular Surgery c September 2011Thoralf M. Sundt III, MD, Boston, Masse93 Cardiac support device, restrictive mitral valve annuloplasty, and optimized
medical treatment: A multimodality approach to nonischemic cardiomyopathy
Jerry Braun, MD, Agnieszka Ciarka, MD, PhD, Michel I. M. Versteegh, MD,
Victoria Delgado, MD, Eric Boersma, MD, PhD, Harriette F. Verwey, MD, PhD,
Martin J. Schalij, MD, PhD, Jeroen J. Bax, MD, PhD, Robert A. E. Dion, MD, PhD,
Nico R. van de Veire, MD, PhD, and Robert J. M. Klautz, MD, PhD,
Leiden and Rotterdam, The Netherlands; and Genk, BelgiumAn individualized combined medico–surgical approach to nonischemic dilated cardiomyopathy,
using restrictive mitral annuloplasty with or without a cardiac support device and optimal medical
therapy, leads to favorable survival and improved functional status, low incidence of recurrent
mitral regurgitation, and sustained reverse left ventricular remodeling at 3.1 years’ median
follow-up.e101 Descending aortic diameter of 5.5 cm or greater is not an accurate predictor of
acute type B aortic dissection
Santi Trimarchi, MD, Frederik H. W. Jonker, MD, Stuart Hutchison, MD,
Eric M. Isselbacher, MD, Linda A. Pape, MD, Himanshu J. Patel, MD,
James B. Froehlich, MD, MPH, Bart E. Muhs, MD, PhD, Vincenzo Rampoldi, MD,
Viviana Grassi, MD, Arturo Evangelista, MD, Gabriel Meinhardt, MD, Joshua Beckman, MD,
Truls Myrmel, MD, Reed E. Pyeritz, MD, Alan T. Hirsch, MD, Thoralf M. Sundt III, MD,
Christoph A. Nienaber, MD, and Kim A. Eagle, MD, Milan, Italy; New Haven, Conn; Calgary,
Alberta, Canada; Boston and Worcester, Mass; Ann Arbor, Mich; Barcelona, Spain; Stuttgart and
Rostock, Germany; Tromso, Norway; Philadelphia, Pa; and Minneapolis and Rochester, MinnThe descending aortic diameter at presentation of 613 patients with acute type B aortic dissection
enrolled in the IRAD between 1996 and 2009 was examined. Only 18.4% of patients had an aortic
diameter of 5.5 cm or greater; thus, the majority of patients with acute type B aortic dissection are
not within the guidelines for elective descending thoracic aortic repair.e109 Randomized controlled trial of brief cognitive behavioral intervention for
depression and anxiety symptoms preoperatively in patients undergoing
coronary artery bypass graft surgery
Tam K. Dao, PhD, Nagy A. Youssef, MD, Mary Armsworth, Emily Wear,
Katina N. Papathopoulos, and Raja Gopaldas, MD, Houston, Tex, Durham, NC,
Mobile, Ala, and Columbia, MoThis study examined the feasibility, acceptability, and efficacy of a cognitive–behavioral
intervention for coronary artery bypass graft (CABG) patients with preoperative symptoms of
depression or anxiety. Results of the study suggest that targeting preoperative depression and
anxiety is both feasible and acceptable for these patients.e117 Do higher-risk patients benefit from off-pump coronary artery bypass
grafting? Evidence from an ecologic analysis of randomized trials
Oliver Kuss, PhD, and Jochen B€orgermann, MD, Halle (Saale) and Bad Oeynhausen, GermanyIn an ecologic analysis of all randomized trials that compared off-pump and on-pump coronary
artery bypass grafting we found a superiority of the off-pump technique in patients with lower
ejection fraction values, especially for the most valid outcome of mortality.)










Se24A The Journal of Thoracic an123 SYNTAX Score is associated with worse outcomes after off-pump coronary
artery bypass grafting surgery for three-vessel or left main complex coronary
disease(continued on page 26A
d Cardiovascular Surgery c September 2011Manuel Carnero-Alcazar, MD, Luis C. Maroto Castellanos, MD, PhD,
Jacobo A. Silva Guisasola, MD, PhD, Javier Cobiella Carnicer, MD, Ali Alswies, MD,
Manuel E. Fuentes Ferrer, MD, PhD, and Jose E. Rodrıguez Hernandez, MD, Madrid, SpainThe association between SYNTAX Score and early and midterm outcomes after off-pump coronary
artery bypass grafting for left main or 3-vessel disease was studied. Multivariate analyses adjusted
for a balancing score proved a statistically significant association between SYNTAX Score and
early and midterm combined MACCE (including death, stroke, myocardial infarction, and repeat
revascularization). SYNTAX Score was not associated with early or midterm mortality.Perioperative
Management (PM)
650 Society of Thoracic Surgeons Risk Score predicts hospital charges and resource
use after aortic valve replacement
George J. Arnaoutakis, MD, Timothy J. George, MD, Diane E. Alejo, BA,
Christian A. Merlo, MD, MPH, William A. Baumgartner, MD, Duke E. Cameron, MD, and
Ashish S. Shah, MD, Baltimore, MdThis study examined the impact of high STSmortality risk score on hospital charges in 553 patients
undergoing AVR at a single institution. Increasing STS scores were associated with increased
hospital charges in a linear relationship. These results are a benchmark for future comparisons
between traditional and percutaneous AVR.656 Perioperative aminoglycoside treatment is associatedwith a higher incidence of
postoperative dialysis in adult cardiac surgery patients
Dorthe Viemose Nielsen, MD, Vibeke Hjortdal, MDSci, Heidi Larsson, MSc,
Søren Paske Johnsen, PhD, and Carl-Johan Jakobsen, MD, Skejby and Aarhus, DenmarkThe effect of perioperative aminoglycoside treatment on the risk of acute kidney injury requiring
dialysis in patients undergoing cardiac surgery remains uncertain. In a register study among 3587
patients, perioperative use of aminoglycosides in adults undergoing cardiac surgery was associated
with increased risk of postoperative dialysis.662 Bleeding and management of coagulopathy
Roman M. Sniecinski, MD, and Jerrold H. Levy, MD, FAHA, Atlanta, GaThe causes of bleeding after cardiac surgery are multi-factorial, including dilution of factors,
ongoing fibrinolysis, and platelet dysfunction. This review will highlight current concepts in the
evaluation and treatment of this coagulopathy.Evolving Technology/
Basic Science (ET/BS)
668 Transapical miniaturized ventricular assist device: Design and initial testing
Mark S. Slaughter, MD, Guruprasad A. Giridharan, PhD, Dan Tamez, BS, Jeff LaRose, MS,
Mike A. Sobieski, RN, CCP, Leslie Sherwood, DVM, and Steven C. Koenig, PhD, Louisville, Ky, and
Miami Lakes, FlaHeartWare (Miami Lakes, Fla) is developing a miniature ventricular assist device that can be
implanted off pump and using less invasive surgery. The clinical benefits of the HeartWare MVAD
include the opportunity to treat patients with less advanced HF, improved patient outcomes, shorter
recovery times, and lower hospital costs.)










S626A The Journal of Thoracic an75 Hypercholesterolemia and chronic ischemia alter myocardial responses to
selective cyclooxygenase-2 inhibition(continued on page 28A
d Cardiovascular Surgery c September 2011Louis M. Chu, MD, Michael P. Robich, MD, Antonio Lassaletta, MD, Thomas Burgess, MS,
Yuhong Liu, MD, Nicholas Sellke, and Frank W. Sellke, MD, Providence, RI, and Boston, MassCyclooxygenase-2 inhibitors have been implicated in adverse cardiac events, but the effects of
cardiovascular comorbidities on selective COX inhibition are unknown. In this study, we
investigate the effects of myocardial ischemia and hypercholesterolemia on cardiovascular function
in the setting of celecoxib administration.682 Determination of the elastic modulus of ascending thoracic aortic aneurysm at
different ranges of pressure using uniaxial tensile testing
Khalil Khanafer, PhD, Ambroise Duprey, MD, Mohammad Zainal, PhD, Marty Schlicht, PhD,
David Williams, MD, and Ramon Berguer, PhD, MD, Ann Arbor, Mich, St Etienne, France, and
Safat, KuwaitWe provide measurements of the elastic moduli of the walls of ascending aortic aneurysms at
normotensive and hypertensive ranges to facilitate the understanding of the mechanics of
aneurysmal rupture.687 Downregulation of the CXC chemokine receptor 4/stromal cell–derived factor
1 pathway enhances myocardial neovascularization, cardiomyocyte survival,
and functional recovery after myocardial infarction
Nikolaos Bonaros, MD, PhD, Hugo Sondermeijer, MS, MD, Dominik Wiedemann, MD,
Bernhard Schlechta, MD, Thomas Schachner, MD, Michael Schuster, MSc, Tetsunori Seki, PhD,
Timothy P. Martens, MD, Silviu Itescu, MD, and Alfred A. Kocher, MD, Innsbruck and Vienna,
Austria; Melbourne, Australia; and New York, NYBone marrow stromal cell–derived factor 1 (SDF-1) upregulation after myocardial ischemia
prevents mobilization of endogenous hematopoietic progenitors. Disruption of SDF-1/CXC
chemokine receptor 4 interactions allows redirection of hematopoietic progenitors from the bone
marrow to the ischemic heart, augments neovascularization and cardiomyocyte survival, and
enhances recovery of left ventricular function.697 Saddle-shaped mitral valve annuloplasty rings improve leaflet coaptation
geometry
Morten O. Jensen, PhD, Henrik Jensen, MD, PhD, Robert A. Levine, MD, Ajit P. Yoganathan, PhD,
Niels Trolle Andersen, PhD, Hans Nygaard, DMSc, J. Michael Hasenkam, MD, DMSc, and
Sten L. Nielsen, MD, PhD, DMSc, Aarhus, Denmark, Boston, Mass, and Atlanta, GaThe systolic saddle shape of the mitral valve annulus is believed to put the leaflets into
a lower-energy equilibrium. Annuloplasty rings conforming to this shape provide better leaflet
coaptation geometry than do flat rings.Cardiothoracic
Imaging
704 Unusual papillary muscle hypertrophy in a septuagenarian
Nikhil Prakash Patil, MS, MRCS (England), and Karuna Katti, MS, New Delhi and Gurgaon,
India706 Annular intimal tear of the aortic root misdiagnosed as aortic regurgitation
Chun Wang, MD, Zongyi Xiu, MD, and Tianxiang Gu, MD, Shenyang, China)
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d Cardiovascular Surgery c September 2011Ares K. Menon, MD, Guido Dohmen, MD, Andreas H. Mahnken, MD, MBA, and
R€udiger Autschbach, MD, PhD, Aachen, Germany710 Endovascular repair of arterio-bronchial fistula of the outflow graft of
HeartMate II left ventricular assist device
Roh Yanagida, MD, PhD, Robert Kass, MD, Lawrence Czer, MD, and Ali Khoynezhad, MD,
Los Angeles, Calif712 Management of HeartWare left ventricular assist device thrombosis using
intracavitary thrombolytics
Michael S. Kiernan, MD, Duc Thinh Pham, MD, David DeNofrio, MD, and Navin K. Kapur, MD,
Boston, Mass714 Video-assisted thoracoscopic surgical tracheobronchoplasty for
tracheobronchomalacia
David G. Tse, MD, Sukgu M. Han, MD, Burawit Charuworn, MD, and Eric S. Kaufer, MD,
Los Angeles, Calif716 Anterior leaflet augmentation for ischemic mitral regurgitation in patients with
anomalous left coronary artery from the pulmonary artery and preserved left
ventricular function
Michael H. Hines, MD, Edward H. Kincaid, MD, Amanda L. Cook, MD, and
Neal D. Kon, MD, Winston–Salem, NCOnline Only:
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e133 Emergency surgery for macrocystic lymphatic malformation in the lung of
a neonate
Mamoru Takahashi, MD, Norihito Okumura, MD, Kotaro Kameyama, MD, and
Kenji Notohara, MD, Okayama, Japane135 Surgical repair of both atrioventricular valves in congenitally corrected
transposition of the great arteries with dextrocardia
Yutaka Koyama, MD, Shunsuke Fukaya, MD, Hideki Kitamura, MD, and
Masashi Komeda, MD, PhD, Nagoya, Japane136 Migration of retained right ventricular epicardial pacing wire into the
pulmonary artery: A rare complication after heart surgery
Patrick J. Worth, BA, Patrick Conklin, MD, Ethan Prince, MD, and
Arun K. Singh, MD, FRCS(C), Providence, RIe138 A new era: Use of an intracorporeal systemic ventricular assist device to
support a patient with a failing Fontan circulation
David L. S. Morales, MD, Iki Adachi, MD, Jeffrey S. Heinle, MD, and
Charles D. Fraser, Jr, MD, Houston, Texe140 The use of the HeartWare HVAD for long-term right ventricular support after
implantation of the HeartMate II device
John M. Stulak, MD, Kevin E. Griffith, John M. Nicklas, MD, and Francis D. Pagani, MD, PhD,
Ann Arbor, Mich)
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